Thrombus is the main problem in the pathogenesis of acute coronary syndrome (ACS). Antithrombotic agents are the mainstay of the therapy in ACS. The major goal of optimal antithrombotic therapy for patients with ACS is to minimize the risk of early- and long-term thrombotic adverse events, as well as to reduce risk of bleeding complications. Sun Pharma and Docplexus had organized an interactive Webinar on 4 th September 2017 at 3 :00 pm . In this webinar session, Dr.
Y. Vijayacharya Reddy, Dr. Kumaresan Kannan and Dr. J Ezhilan discussed “Choice of DAPT for PCI ." This is the recorded version of the Webinar.
